Inotiv Inc. (NOTV)
4.19
-0.03 (-0.71%)
At close: Jan 14, 2025, 3:59 PM
4.04
-3.58%
After-hours Jan 14, 2025, 05:28 PM EST
undefined% (undefined)
| Bid | 3.9 |
| Market Cap | 134.14M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -4.19 |
| PE Ratio (ttm) | -1 |
| Forward PE | n/a |
| Analyst | Strong Buy |
| Ask | 4.77 |
| Volume | 828,249 |
| Avg. Volume (20D) | 840,763 |
| Open | 4.43 |
| Previous Close | 4.22 |
| Day's Range | 3.98 - 4.43 |
| 52-Week Range | 1.23 - 11.42 |
| Beta | undefined |
About NOTV
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, r...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Nov 25, 1997
Employees 1,955
Stock Exchange NASDAQ
Ticker Symbol NOTV
Website https://www.inotivco.com
Analyst Forecast
According to 3 analyst ratings, the average rating for NOTV stock is "Strong Buy." The 12-month stock price forecast is $4, which is a decrease of -4.53% from the latest price.
Buy 66.67%
Hold 33.33%
Sell 0.00%
Next Earnings Release
Inotiv Inc. is scheduled to release its earnings on Feb 5, 2025,
during market hours.
Analysts project revenue of $122.74M, reflecting a -9.42% YoY shrinking and earnings per share of -0.32, making a -46.67% decrease YoY.
Analysts project revenue of $122.74M, reflecting a -9.42% YoY shrinking and earnings per share of -0.32, making a -46.67% decrease YoY.
4 weeks ago ·
Source
-28.83%
Inotic shares are trading lower after the company ...
Unlock content with
Pro Subscription
4 weeks ago ·
Source
-4.48%
Inotic shares are trading lower after the company announced a public offering of common shares with a 15% over-allotment option.
